Business
Australia strikes deal for new Covid pill that could be used in treatment by early 2022 – The Guardian Australia
Molnupiravir has been shown to prevent serious illness and death, although it is still in late stage clinical trials
Australia has secured 300,000 courses of molnupiravir, an antiviral capsule to treat Covid-19 that could be in use by early 2022.
The Morrison government has struck a supply agreement with MSD to provide the oral treatment if it is approved by the Therapeutic…
Continue Reading
-
Noosa News17 hours agoWhy buying a home in this surprise suburb could save you $400,000
-
Noosa News16 hours agoUncertainty still surrounds government pay deals with police, teachers, and nurses and midwives
-
Business15 hours agoBell Potter names cheap ASX dividend shares to buy now
-
Noosa News16 hours agoMassive drone carries national flag in breathtaking Ekka moment in Brisbane